Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

Gene Therapy Study for Children With CLN5 Batten Disease

← catalyst calendar

NCT05228145 · readout ≤ 834 d

Sponsored by Neurogene Inc. (industry) · NGNE — their whole pipeline →.

Phase
Phase 1/2
Status
Active, not recruiting
Study type
Interventional
Design
Non randomized · None · Treatment
Enrollment
6actual
Sites
2
Countries
United Kingdom, United States

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2022-01-31actualWhen the study began enrolling
Primary completionNov 2028estimatedThe date the last participant is measured for the primary outcome — the readout window
Study completionNov 2028estimatedThe whole study's end, after follow-up
First posted2022-02-08actualWhen this record first appeared on the registry
Results postedWhen the sponsor posted results to the registry
Record updated2024-08-12actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Condition

  • Neuronal Ceroid Lipofuscinosis CLN5

Intervention

  • Genetic: NGN-101

Primary outcomes

what the primary-completion date above is the date OF
Incidence of Treatment Emergent Adverse Events (TEAEs)
measured 5 years (multiple visits)
Incidence of Serious Adverse Events (SAEs)
measured 5 years (multiple visits)
Incidence of clinical laboratory abnormalities
measured 5 years (multiple visits)
Incidence of new nerve conduction study (NCS) abnormalities
measured 5 years (multiple visits)
Incidence of new physical and neurologic exam abnormalities
measured 5 years (multiple visits)

Publications

Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.

Permalink · NGNE's whole pipeline · Catalyst calendar · Every registered study · What changed